DETEKSI DINI RISIKO SINDROM METABOLIK MELALUI PEMERIKSAAN KOLESTEROL TOTAL DAN HDL PADA KOMUNITAS GEREJA BAPTIS CENGKARENG
Keywords:
dislipidemia, HDL, kolesterol, komunitas, skriningAbstract
Dislipidemia, terutama peningkatan kolesterol total dan penurunan HDL, merupakan komponen penting sindrom metabolik yang meningkatkan risiko kardiovaskular. Skrining berbasis komunitas diperlukan untuk meningkatkan deteksi dini pada populasi yang belum terjangkau layanan kesehatan. Metode: Kegiatan pengabdian kepada masyarakat ini menggunakan desain observasional deskriptif berbasis komunitas pada jemaat dewasa di Gereja Baptis Cengkareng, Jakarta (n=109). Kegiatan ini mencakup pemeriksaan kolesterol total dan HDL, disertai edukasi kesehatan. Analisis dilakukan secara deskriptif dengan mengacu pada kriteria NCEP ATP III. Hasil: Rerata usia peserta 42,81±13,55 tahun dengan dominasi perempuan (67,9%). Rerata kolesterol total 213,28±42,14 mg/dL, dengan 61,5% mengalami hiperkolesterolemia. Rerata HDL 45,49±13,03 mg/dL, dengan sebagian besar peserta berada pada kategori rendah (47,7%) dan sangat rendah (35,8%). Distribusi kolesterol menunjukkan kecenderungan meningkat seiring usia, meskipun dengan variasi yang luas. Kesimpulan: Skrining profil lipid berbasis komunitas efektif dalam mengidentifikasi tingginya beban dislipidemia dan berpotensi menjadi strategi promotif-preventif dalam menurunkan risiko kardiovaskular melalui deteksi dini dan edukasi
References
Achila, O. O., Fessahye, N., Mengistu, S. T., Habtemikael, N. T., Werke, W. Y., Zemichael, F. T., Leghese, H. N., Weldegegish, T. A., Tekeste, T. H., & Garoy, E. Y. (2022). A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea. Scientific Reports, 12(1), 5567. https://doi.org/10.1038/s41598-022-09446-9
Anand, C., Kranz, R.-M., Husain, S., Koeder, C., Schoch, N., Alzughayyar, D.-K., Gellner, R., Hengst, K., & Englert, H. (2022). Bridging the gap between science and society: long-term effects of the Healthy Lifestyle Community Programme (HLCP, cohort 1) on weight and the metabolic risk profile: a controlled study. BMJ Nutrition, Prevention & Health, 5(1), 44–54. https://doi.org/10.1136/bmjnph-2021-000340
Arvanitis, M., & Lowenstein, C. J. (2023). Dyslipidemia. Annals of Internal Medicine, 176(6), ITC81–ITC96. https://doi.org/10.7326/AITC202306200
Ben-Assayag, H., Brzezinski, R. Y., Berliner, S., Zeltser, D., Shapira, I., Rogowski, O., Toker, S., Eldor, R., & Shenhar-Tsarfaty, S. (2023). Transitioning from having no metabolic abnormality nor obesity to metabolic impairment in a cohort of apparently healthy adults. Cardiovascular Diabetology, 22(1), 226. https://doi.org/10.1186/s12933-023-01954-w
Chung, K. W. (2021). Advances in Understanding of the Role of Lipid Metabolism in Aging. Cells, 10(4), 880. https://doi.org/10.3390/cells10040880
Deng, Y.-Y., Ngai, F.-W., Qin, J., Yang, L., Wong, K.-P., Wang, H.-H., & Xie, Y.-J. (2024). Combined Influence of Eight Lifestyle Factors on Metabolic Syndrome Incidence: A Prospective Cohort Study from the MECH-HK Study. Nutrients, 16(4), 547. https://doi.org/10.3390/nu16040547
Feng, L., Nian, S., Tong, Z., Zhu, Y., Li, Y., Zhang, C., Bai, X., Luo, X., Wu, M., & Yan, Z. (2020). Age-related trends in lipid levels: a large-scale cross-sectional study of the general Chinese population. BMJ Open, 10(3), e034226. https://doi.org/10.1136/bmjopen-2019-034226
Flores Soler, J., Vila Costa, I., Bengoa Terrero, C., Fernandez Perez, C., Garcia Gonzalez, F., Bas Villalobos, M., Perez-Villacastin Dominguez, J., & Villares, J. (2024). Prevecardio: a single-visit population screening model for detection and prevention of 10-year cardiovascular risk. European Heart Journal, 45(Supplement_1). https://doi.org/10.1093/eurheartj/ehae666.3606
Giangregorio, F., Mosconi, E., Debellis, M. G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., Kaloudi, O., Mustafazade, G., Marín-Baselga, R., & Tung-Chen, Y. (2024). A Systematic Review of Metabolic Syndrome: Key Correlated Pathologies and Non-Invasive Diagnostic Approaches. Journal of Clinical Medicine, 13(19), 5880. https://doi.org/10.3390/jcm13195880
Gusnedi, G., Fahmida, U., Witjaksono, F., Nurwidya, F., Mansyur, M., Djuwita, R., Dwiriani, C. M., & Abdullah, M. (2022). Effectiveness of optimized food-based recommendation promotion to improve nutritional status and lipid profiles among Minangkabau women with dyslipidemia: A cluster-randomized trial. BMC Public Health, 22(1), 21. https://doi.org/10.1186/s12889-021-12462-5
Harmadha, W. S. P., Muharram, F. R., Gaspar, R. S., Azimuth, Z., Sulistya, H. A., Firmansyah, F., Multazam, C. E. C. Z., Harits, M., & Putra, R. M. (2023). Explaining the increase of incidence and mortality from cardiovascular disease in Indonesia: A global burden of disease study analysis (2000–2019). PLOS ONE, 18(12), e0294128. https://doi.org/10.1371/journal.pone.0294128
Herningtyas, E. H., & Ng, T. S. (2019). Prevalence and distribution of metabolic syndrome and its components among provinces and ethnic groups in Indonesia. BMC Public Health, 19(1), 377. https://doi.org/10.1186/s12889-019-6711-7
Huang, J.-K., & Lee, H.-C. (2022). Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). International Journal of Molecular Sciences, 23(8), 4300. https://doi.org/10.3390/ijms23084300
Moniaga, C. S., Noviantri, J. S., Yogie, G. S., Firmansyah, Y., & Hendsun, H. (2023). Kegiatan Pengabdian Masyarakat dalam Edukasi Penyakit Dislipidemia serta Komplikasinya terhadap Penyakit Kardiovaskular. Jurnal Kabar Masyarakat, 1(2), 20–30.
Park, Y. S., Kang, S. H., Jang, S.-I., & Park, E.-C. (2022). Association between lifestyle factors and the risk of metabolic syndrome in the South Korea. Scientific Reports, 12(1), 13356. https://doi.org/10.1038/s41598-022-17361-2
Peterseim, C. M., Jabbour, K., & Kamath Mulki, A. (2024). Metabolic Syndrome: An Updated Review on Diagnosis and Treatment for Primary Care Clinicians. Journal of Primary Care & Community Health, 15. https://doi.org/10.1177/21501319241309168
Sarkar, S., Prasanna, V. S., Das, P., Suzuki, H., Fujihara, K., Kodama, S., Sone, H., Sreedhar, R., Velayutham, R., Watanabe, K., & Arumugam, S. (2024). The onset and the development of cardiometabolic aging: an insight into the underlying mechanisms. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1447890
Stellaard, F. (2022). From Dietary Cholesterol to Blood Cholesterol, Physiological Lipid Fluxes, and Cholesterol Homeostasis. Nutrients, 14(8), 1643. https://doi.org/10.3390/nu14081643
Thongtang, N., Sukmawan, R., Llanes, E. J. B., & Lee, Z.-V. (2022). Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices. Preventive Medicine Reports, 27, 101819. https://doi.org/10.1016/j.pmedr.2022.101819
Yan, Z., Xu, Y., Li, K., & Liu, L. (2024). Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus: dual evidence from NHANES database and Mendelian randomization analysis. Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1272314
Zheng, W., Zhang, J., Jiang, Y., Wang, S., & Yang, Z. (2024). Overlapping Pattern of the Four Individual Components of Dyslipidemia in Adults: Analysis of Nationally Representative Data. Journal of Clinical Medicine, 13(12), 3624. https://doi.org/10.3390/jcm13123624
